iPhone | iPad
Android
Huawei
Hospitals brace for uptick in typhoid and bacterial infections; and mosquito- and fly-borne diseases like dengue
KT APPDOWNLOAD
J&J signs potential $500 mln drug deal with Astex
LONDON - Britain's Astex Therapeutics has signed a cancer drug research deal with Johnson & Johnson potentially worth more than $500 million in milestone payments, it said on Monday.
The privately owned biotech company will receive upfront payments, cash and equity payments and research funding of $37.4 million over two years under the agreement.
The deal grants a worldwide licence to J&J's Janssen unit to develop and commercialise compounds arising from Astex's FGFR inhibitor programme and establishes a novel drug discovery programme focused on two further cancer drug targets.
Fibroblast Growth Factor Receptor, or FGFR, activates a biochemical pathway that promotes cell growth and is thought to play a role in multiple myeloma, breast, prostate, colon and bladder cancers.
Total payments, excluding royalties, would be worth over $500 million to Astex, assuming one product from each programme is successfully commercialised in all territories, Astex said.
The deal is a further vindication of the Cambridge-based company's fragment-based drug discovery platform, known as Pyramid.
Astex already has existing alliances with other major drugmakers, including Novartis AG, AstraZeneca Plc, Bayer AG and Boehringer Ingelheim.
Astex was established in 1999 and has raised more than 70 million pounds ($138.4 million) in external finance. Its investors include Abingworth Management, Advent International, Alta Partners, Apax, Bayer, GIMV, HypoVereinsbank, Novartis, Oxford Bioscience Partners and the University of Cambridge.
More news from
With 30% of their inventory damaged, owners of Preloved Books now face the daunting task of rebuilding from scratch
Five-time champions hold their nerve to claim victory by nine runs in the final over at Chandigarh
Natasha Abbas is a British civil engineer who co-founded North 51, a project management consultancy in Dubai
People who are assessing your qualifications can quickly tell the difference between an authentic life narrative and a third-party account
Arab-Canadian public speaking coach and author of The Million Dollar Speaker Maher Elusini on how to make your speech command value for time and money
The legendary Greek-Russian conductor Teodor Currentzis, who is all set to perform at the Dubai Opera next week, on music transcending cultural and language barriers
Not every kid is meant to go to university or college. So, it makes sense to teach them entrepreneurial skills early
